Erythroid but not cytogenetic response in a case with 5q− syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

Author： Vigna Ernesto Recchia Anna Grazia Cuzzola Maria Morabito Lucio Gentile Massimo Morabito Fortunato

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1408-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Analysis of the efficacy of lenalidomide in patients with intermediate1 risk myelodysplastic syndrome without 5q deletion

Experimental and Therapeutic Medicine, Vol. 6, Iss. 3, 2013-01 ,pp. : 803-807

Spandidos Publications

Access to resources Recommend Favorite

Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

By Prebet Thomas Charbonnier Aude Gelsi-Boyer Véronique Mozziconacci Marie Joelle Blaise Didier Vey Norbert

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1538-1540

Informa Healthcare

Access to resources Recommend Favorite

Response to lenalidomide of a patient with t(2;3)(p23;q29) and JAK2 non-mutated refractory anemia with ring sideroblasts and thrombocytosis

By Zhang Min

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1544-1546

Informa Healthcare

Access to resources Recommend Favorite

Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2931-2936

Spandidos Publications

Access to resources Recommend Favorite

Diagnosis and treatment of SAPHO syndrome: A case report

Experimental and Therapeutic Medicine, Vol. 8, Iss. 2, 2014-01 ,pp. : 419-422

Spandidos Publications

Access to resources Recommend Favorite